[19] [20] More serious but rare risks include pancreatitis (severe abdominal pain radiating to the back), gallbladder disease (right upper quadrant pain, fever, jaundice), and potential thyroid C-cell tumors (based on animal data)
The science of Microdosing Tirzepatide Dual-action by design: Tirzepatide is the first dual GIP and GLP-1 receptor agonist
Contact your compounding pharmacy for clarification
1.25mg 2.5mg 5mg 2x/week 2 injections/week P/T Ratio: ~2.1 Peak Reduction: 28% 3
Sensations vary in quality and time Patients with small fiber neuropathy typically present with a symmetric length-dependent (stocking-glove) distribution of sensory changes, starting in the feet and gradually ascending up the legs and then to the hands
With the weight-loss bar already at 20%-plus, greater emphasis is likely to be placed on improving tolerability and the quality of weight loss, with nonincretin mechanisms, such as amylin, in focus